Therapeutic options in older patients with metastatic non-small cell lung cancer
The increase in life expectancy, with its concomitant increase in the risk of cancer, has led to an increased incidence of lung cancer in older people. The median age at diagnosis of lung cancer is between 63 and 70 years. For a long time, there has been a pessimistic attitude by doctors, patients a...
Main Author: | Elisabeth Quoix |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-09-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758834012455838 |
Similar Items
-
Topotecan in the treatment of relapsed small cell lung cancer
by: Elisabeth Quoix
Published: (2008-12-01) -
New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer
by: Weise AM, et al.
Published: (2014-08-01) -
Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer
by: Tani T, et al.
Published: (2021-09-01) -
Anaplastic lymphoma kinase-positive metastatic non-small-cell lung cancer: Emerging resistance and treatment options
by: Amba Prasad Dubey, et al.
Published: (2020-01-01) -
Personalized treatment options for ALK-positive metastatic non-small-cell lung cancer: potential role for Ceritinib
by: El-Osta H, et al.
Published: (2015-09-01)